跳至主要内容
临床试验/CTRI/2019/07/020132
CTRI/2019/07/020132尚未招募不适用

A Comparative clinical trial on Therapeutic efficasy of Nasiyam application and Seenthil Choornam in the management of Neerpeenisam(Sinusitis).

DrArsha Mohan1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年11月8日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
To evaluate the therapeutic efficacy of Nasiyam and seenthil chooranam in the management of Peenisam (Sinusitis)

研究概览

简要总结

This is a  clinical trial to evaluate the therapeutic efficacy of Nasiyam application on Neer Peenisam (Sinusitis) cases reporting in Ayodidoss Pandithar Hospital of National Institute of Siddha.Acute sinusitis is the second most common infectious diseases seen in general pratice.In the classical text Book of Agasthiyar paripooram -400 menctioned the procedure of Nasiyam for healing Peenisam(Sinusitis).The drugs mentioned in this preparation pocess mostly of hot potency and bitter taste which reduses kabha.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1 Patient suffering from acute and chronic sinusitis 2 Patient with symptoms of headache,watery discharge from nostrils,odour of meat wash,redness of eyes,tenderness on face.
  • 3 Patients willing for investigations.
  • 4 Patient willing to undergo informed consent.
  • 5 patient willing to sign consent stating he or she will conscientiously stick to treatment during 45 days but can opt out of trial of his or her own concious.

排除标准

  • 1 Patient with evidence of Malignancy 2 Patient having tuberculosis or any other respiratory infectious disease 3 History of cardiac diseases 4 History of uncontrolled hypertension 5 History of Chronic kidney diseases 6 Pregnancy and lactation 7 Patient with any other chronic systemic illness.

结局指标

主要结局

To evaluate the therapeutic efficacy of Nasiyam and seenthil chooranam in the management of Peenisam (Sinusitis)

时间窗: 45 days

次要结局

  • To assess which kind of patients affect more on Peenisam and their response to trial drug.(45 days)

研究者

发起方
DrArsha Mohan
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验